Evidence map›Paper›PMID 38711522›Full record

ArticleFrontiers in immunology2024

Case report: Experience and insights on the treatment of two cases of cryptococcal meningitis during the later stages of the COVID-19 pandemic.

Yuli Zhou, Bingfeng Qiu, Jun Jiang, Tianwen Chen, Liqian Wang, Yunxing Yang, Senlin Ruan, Yanlei Chen, Huanli Fang, Juan Jin and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuli Zhou *Department of Laboratory Medicine, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, China.
Bingfeng Qiu *Department of Laboratory Medicine, People's Hospital of Tonglu County, Hangzhou, Zhejiang, China.
Jun Jiang *Marketing Department, Guilin URIT Medical Electronic Co., Ltd., Guilin, Guangxi, China.
Tianwen ChenDepartment of Neurology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, China.
Liqian WangDepartment of Laboratory Medicine, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, China.
Yunxing YangDepartment of Laboratory Medicine, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, China.
Senlin RuanDepartment of Laboratory Medicine, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, China.
Yanlei ChenDepartment of Laboratory Medicine, People's Hospital of Tonglu County, Hangzhou, Zhejiang, China.
Huanli FangDepartment of Laboratory Medicine, People's Hospital of Tonglu County, Hangzhou, Zhejiang, China.
Juan JinDepartment of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, China.
Nan YangDepartment of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the late stages of the COVID-19 pandemic, there's an increasing trend in opportunistic infections, including bacterial and fungal infections. This study discusses the treatment process of two cases of cryptococcal meningitis during the COVID-19 pandemic. It highlights the importance of laboratory testing for these co-infections and stresses the need for vigilance, early diagnosis, and proactive treatment to improve patient outcomes in the post-pandemic era.

Indexed as

Antifungal AgentsCOVID-19Meningitis, CryptococcalSARS-CoV-2AdultCoinfectionCryptococcus neoformansFemaleHumansMaleMiddle AgedTreatment OutcomeAntifungal Agentscerebrospinal fluid morphologycryptococcal meningitislaboratory examinationsnovel coronavirusopportunistic infections

Identifiers

PMID38711522
PMCPMC11072183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.